FDA Advisers Who Approved Yaz Tied to Drug Companies

Last month, the FDA asked a panel of outside experts whether the blood clot risk for newer birth control pills like Yaz and Yasmin was significant enough to pull the drugs from the market. The panel found that the risk is worth it to prevent pregnancy (which is an even bigger clot risk), but the narrow margin didn't…
